drugset / Trial / NCT05710887

N2O for Acute Suicidality and Depression in the ED

NCT05710887

Phase 2 Withdrawn University of Chicago
RandomizedParallel-groupDouble-blindTreatment

Summary

Investigators are conducting this double-blind, randomized control trial (RCT), to compare inhaled N2O+ treatment as usual (TAU) versus inhaled placebo+TAU; demonstrating the feasibility and tolerability of the intervention in an emergency department (ED) setting on an acutely suicidal population.

Timeline

Start
2026-02-27
Primary completion
2026-02-27
Completion
2026-02-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitrous Oxide Other / unclassified 50 % Inhaled